Biophore its subsidiary Zenara Pharma receive first approval for Cannabidiol in India

Biophore its subsidiary Zenara Pharma receive first approval for Cannabidiol in India

Biophore India Pharmaceuticals on Monday announced that it has received approval from the Central Drugs Standard Control Organisation(CDSCO) for manufacturing and marketing of Cannabidiol in India. Cannabidiol or CBD, is the active ingredient in the cannabis or hemp plant, and some form of CBD is used for therapeutic purposes for certain medical conditions. A press release from the drug maker said its subsidiary Zenara Pharma has received approval for the final product, Cannabidiol Oral Solution 100mg/ml for use in neurological disorders. The approval currently received is for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex in patients 1 year of age or older. Cannabidiol by Zenara and Biophore has been filed with the USFDA and is awaiting approval. This is the first time ever that a Cannabidiol-based product has been approved in India delivering a unique therapy option. The product is being manufactured at USFDA and EU approved state-of-the-art facilities in Hyderabad and Vishakhapatnam, it said. Jagadeesh Babu Rangisetty, CEO at Biophore, said,

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!